Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Expert Review of Hematology
|
February 7, 2017
When to treat patients with relapsed follicular lymphoma
Chan Yoon Cheah, John F Seymour
Best Practice & Research. Clinical Haematology
|
February 18, 2018
Novel agents for relapsed and refractory follicular lymphoma
Chan Yoon Cheah, Nathan H Fowler
Leukemia & Lymphoma
|
August 20, 2020
Event free survival at 12 months (EFS12) in stage 1 DLBCL - a reassuring milestone?
Katharine L Lewis, Chan Yoon Cheah
Leukemia & Lymphoma
|
March 8, 2024
The value of bispecific antibodies in relapsed and refractory DLBCL
Katharine Louise Lewis, Chan Yoon Cheah
Leukemia & Lymphoma
|
August 23, 2017
Questioning the value of routine imaging for patients with mantle cell lymphoma in first remission
Tarec C El-Galaly, Chan Yoon Cheah
British Journal of Haematology
|
January 31, 2020
Mantle cell lymphoma - where precision medicine based on response-adapted treatment strategies could show its full worth
Tarec Christoffer El-Galaly, Chan Yoon Cheah
Expert Review of Hematology
|
January 12, 2026
Approaches to the management of relapsed/refractory mantle cell lymphoma: navigating an increasingly complex therapeutic landscape
Wan Danial Noor, Diego Villa, Chan Yoon Cheah
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Novel treatments for T-cell lymphoma
Chan Yoon Cheah, Yasuhiro Oki, Michelle A Fanale
Current Opinion in Oncology
|
August 7, 2015
Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
Chan Yoon Cheah, Nathan H Fowler, Sattva S Neelapu
American Journal of Hematology
|
March 23, 2026
Marginal Zone Lymphoma: 2026 Update on Diagnosis and Management
Wan Danial Noor, John F Seymour, Chan Yoon Cheah
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Expert Review of Hematology
|
February 7, 2017
When to treat patients with relapsed follicular lymphoma
Chan Yoon Cheah, John F Seymour
Best Practice & Research. Clinical Haematology
|
February 18, 2018
Novel agents for relapsed and refractory follicular lymphoma
Chan Yoon Cheah, Nathan H Fowler
Leukemia & Lymphoma
|
August 20, 2020
Event free survival at 12 months (EFS12) in stage 1 DLBCL - a reassuring milestone?
Katharine L Lewis, Chan Yoon Cheah
Leukemia & Lymphoma
|
March 8, 2024
The value of bispecific antibodies in relapsed and refractory DLBCL
Katharine Louise Lewis, Chan Yoon Cheah
Leukemia & Lymphoma
|
August 23, 2017
Questioning the value of routine imaging for patients with mantle cell lymphoma in first remission
Tarec C El-Galaly, Chan Yoon Cheah
British Journal of Haematology
|
January 31, 2020
Mantle cell lymphoma - where precision medicine based on response-adapted treatment strategies could show its full worth
Tarec Christoffer El-Galaly, Chan Yoon Cheah
Expert Review of Hematology
|
January 12, 2026
Approaches to the management of relapsed/refractory mantle cell lymphoma: navigating an increasingly complex therapeutic landscape
Wan Danial Noor, Diego Villa, Chan Yoon Cheah
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
Novel treatments for T-cell lymphoma
Chan Yoon Cheah, Yasuhiro Oki, Michelle A Fanale
Current Opinion in Oncology
|
August 7, 2015
Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
Chan Yoon Cheah, Nathan H Fowler, Sattva S Neelapu
American Journal of Hematology
|
March 23, 2026
Marginal Zone Lymphoma: 2026 Update on Diagnosis and Management
Wan Danial Noor, John F Seymour, Chan Yoon Cheah
Page
of 7